Biot Korea Co., Ltd. (CEO Youngjun Jang) announced that it will participate in CES 2024, the world’s largest IT and home appliance exhibition, to be held in Las Vegas, USA in January next year.
Biot Korea is a domestic startup that has secured research and development capabilities in diagnostic robots and medical microrobots, and has recently conducted clinical trials of the ‘PARPIDS Platform’, which automates the nasopharyngeal sample collection process for PCR testing. After completion, it obtained European CE certification.
The RAPIDS platform is expected to be the world’s first medical robot system that collects highly reliable nasopharyngeal swab samples non-face-to-face, remotely, and fully automatically. It is a system that maximizes sustainability in the screening environment for the prolonged respiratory virus pandemic, and enables molecular diagnosis as needed, especially in airports and ports where medical staff cannot be permanently deployed. The company explains that through this, mutant viruses can be effectively blocked at the border.
In the field of therapeutics, we are pursuing the commercialization of the ‘Magnectio Platform’, which minimizes side effects while maximizing effectiveness. Its main function is to accurately deliver active ingredients to target lesions by being guided and localized by magnetic force.
The scaffold made of bioevolutionary material is optimized for loading stem cells, drugs, etc., and the electromagnetic field driving device, which has obtained Class 2 medical device certification from the Ministry of Food and Drug Safety, can increase the targeting efficiency of the scaffold to 90% and guide it to the affected area of the patient. there is. Biot Korea, which has been highly evaluated for its technological excellence, was previously selected for the CES 2023 Innovation Award through its Magnetio platform.
Biot Korea, which seeks to build a sustainable medical environment with next-generation technology, plans to participate in CES 2024 and showcase two types of its medical platform technologies to seek sales channels in the global market.
An official from Biot Korea said, “We are building a foundation for cooperation with global healthcare companies by participating in international exhibitions and expos such as CES, MEDICA, and Arab Health,” and added, “We will enter the North American market through participation in CES 2024.” “We plan to look for global pharmaceutical companies to collaborate with and participate in equity investment,” he said.
He continued, “In addition, we are forming close relationships with pharmaceutical companies in North America and insurance companies in the U.S. through the U.S. Biot corporation, an affiliate of Biot Korea, and discussing the possibility of supply networking and collaboration to local hospitals and pharmacies.” “We are carrying out various promotional activities, such as targeting military networks and promoting our products to many government departments, including ‘Veterans Affairs.’”
Meanwhile, ‘CES’, the world’s largest IT exhibition hosted by the Consumer Technology Association (CTA), is an exhibition where you can see the flow of innovative technologies around the world at a glance and is held every January in Las Vegas, USA. AVING News, which has covered CES for 18 consecutive years, has reported CES news around the world every year since 2006, and has been selected through ‘BEST OF CES’ and ‘BEST OF MADE IN KOREA’, which select the best innovative products, companies and technologies. has been in progress. In addition, CES on-site issues are vividly conveyed through ‘AVING LIVE’.
The CES 2024 Seoul Unified Hall will be operated at the largest scale in terms of exhibition area, number of participating companies, and number of participating supporters since Seoul City’s first participation in CES in 2020. The Seoul Integration Center, in which 13 organizations collaborate and participate, is an important step in Seoul’s efforts to make Seoul a mecca for startups, and 17 of the companies participating in the Seoul Integration Center proved this by receiving innovation awards. The participating institutions in the Seoul Unification Center are ▲SBA ▲Seoul Bio Hub ▲Campus Town ▲AI Yangjae Hub ▲Gwanak-gu ▲Yonsei University ▲Korea University ▲Chung-Ang University ▲Sogang University ▲Kookmin University ▲Hanyang University ▲Konkuk University ▲Kyunghee University. Not only the Seoul Metropolitan Government, institutions, and companies, but also supporters through industry-academia cooperation are matched 1:1 with companies, and 85 supporters, the largest number, will participate.
* Special reporters: Joseph Choe, Kidai Kim, Dongkwan Kim, Mokkyung Lee, Sangun Choi, Seung Hyun Nam, Sunghwan Kim, Taeuck Lim, Min Choi
→ Go to the CES 2024 news special page